TMCnet News
ZYTO Partners with Keiser University & China Functional Medicine Institute to Expand Health ResearchLINDON, Utah, Dec. 07, 2017 (GLOBE NEWSWIRE) -- Last month, ZYTO (OTC PINK:ZYTO) executed a letter of intent together with Keiser University and the China Functional Medicine Institute to cooperate in biocommunication research, academics, and clinical integration. This document was executed at a ceremony in Shanghai, China, by Dr. Vaughn R Cook, CEO of ZYTO, Gavin Chen, Dean of Academic Affairs, Keiser University – Shanghai Off-Campus Site, and Dr. Shaoqing Li, Director for the China Functional Medicine Institute.
A photo accompanying this announcement is available at: Dr. Cook was given by Keiser University the title of Visiting Professor and Director of Keiser Shanghai Big Data Driven Lab for Human Health, and appointed as a Distinguished Professor by the China Functional Medicine Institute. “It’s a great honor to be associated with institutions and organizations with the stature of Keiser University and the China Functional Medicine Institute,” said Dr. Cook. “This begins the launch of significant contributions by all parties to the health and well-being of the Chinese people. We’re pleased to be part of this consortium and are committed to the pursuit of our common objectives.” ZYTO will assist the Keiser University Off-Campus site in Shanghai with its Big Data Program, which was officially approved by the China Ministry of Education earlier this year. The university has set up a base lab at their Shanghai campus for the Big Data Program to foster connections between its students and local healthcare and other industries. About Keiser University Ranked #52 out of 149 prestigious universities by U.S. News & World Report in its 2018 Best Regional Universities South category, Keiser University is accredited by the Southern Association of Colleges and Schools Commission on Colleges to award certificates and degrees at the associate, baccalaureate, masters, specialist, and doctoral levels. The Keiser University Shanghai Off-Campus Site has been operating in China for more than 5 years and continues to expand its presence there. About the China Functional Medicine Institute About ZYTO Forward-looking statements in this release are made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Statements relating to marketing and sales activities by ZYTO’s marketing partners, ZYTO product development launches, future growth and research, and enhanced value for ZYTO’s stockholders are forward-looking statements. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company’s products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time. ZYTO disclaims any obligation or intention to update any forward-looking statement contained in this release. Contact Information Adam Ford |